Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of OKYO Pharma (NASDAQ:OKYO) through any online brokerage.
Other companies in OKYO Pharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
OKYO Pharma has a consensus price target of $5.67.
The stock price for OKYO Pharma (NASDAQ: OKYO) is $1.48 last updated October 7, 2026 at 9:29 AM EDT.
There are no upcoming dividends for OKYO Pharma.
OKYO Pharma does not have any upcoming earnings scheduled.
There is no upcoming split for OKYO Pharma.
OKYO Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.